ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Two cancer center directors named: Michael Kastan at St. Jude, James Willson at Harold Simmons.

December 10, 2004

NCI brings in grantees to explain their work, promise of nanotech, to advisory board.

July 16, 2004

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

NCI Advisory Group, Other Cancer Meetings for October, November

September 24, 1976

NCI Announces New Summer Training Awards

November 12, 1982

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011